Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia

Circulation

Volumn 101, Issue 13, 2000, Pages 1594-1597

  Stefano, George B ^a,b,d   Prevot, Vincent ^c   Beauvillain, Jean Claude ^c   Cadet, Patrick ^a,b   Fimiani, Caterina ^a,b   Welters, Ingeborg ^a,b   Fricchione, Gregory L ^a,b   Breton, Christophe ^e   Lassalle, Philippe ^f   Salzet, Michel ^a,b,c,e   Bilfinger, Thomas V ^a,b,d  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c INSERM   (France)

^d STONY BROOK UNIVERSITY   (United States)

^e UNIV LILLE   (France)

^f INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Calcium; Endothelium; Hormones; Nitric oxide

Indexed keywords

BOVINE SERUM ALBUMIN; CELL SURFACE RECEPTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; TAMOXIFEN;

ADULT; AGED; AMPEROMETRY; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ESTROGEN THERAPY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; INTRACELLULAR TRANSPORT; MALE; MICROFLUOROMETRY; PRIORITY JOURNAL; PROTECTION; VASCULAR ENDOTHELIUM;

EID: 17044455693     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.13.1594     Document Type: Article

References (23)

1. Barret-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA. 1991;265:1861-1867.
2. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 1990;81: 1680-1687.
3. Gruchow HW, Anderson AJ, Barboriak JJ, Sobocinski KA. Postmenopausal use of estrogen and occlusion of coronary arteries. Am Heart J. 1988;115:954-963.
4. Williams JK, Honore EK, Washburn SA, Clarkson TB. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J Am Coll Cardiol. 1994;24:1757-1761.
5. Collins P, Shay J, Jiang C, Moss J. Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal. Circulation. 1994;90:1964-1968.
6. Guetta V, Quyyumi AA, Prasad A, Panza JA, Waclawiw M, Cannon RO. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. Circulation. 1997;96:2795-2801.
7. Bilfinger TV, Hartman A, Liu Y, Magazine HI, Stefano GB. Cryopreserved veins used for myocardial revascularization: a 5 year experience and a possible mechanism for their increased failure. Ann Thorac Surg. 1997;63:1063-1069.
8. Hishikawa K, Nakaki T, Marumo T, Suzuki H, Kato R, Saruta T. Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett. 1995;360:291-293.
9. Hayashi T, Yamada K, Esaki T, Kuzuya M, Satake S, Ishikawa T, Hidaka H, Iguchi A. Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun. 1995;214:847-855.
10. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO. Acute vascular effects of estrogen in postmenopausal women. Circulation. 1994;90:786-791.
11. Reis SE, Gloth ST, Blumenthal RS, Resar JR, Zacur HA, Gerstenblith G, Brinker JA. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation. 1994;89:52-60.
12. Lantin-Hermoso RL, Rosenfeld CR, Yuhanna IS, German Z, Chen Z, Shaul PW. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am J Physiol. 1997;273:L119-L126.
13. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest. 1999;103: 401-406.
14. Razandi M, Pedram A, Greene GL, Levin ER. Cell membrane and nuclear receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells. Mol Endocrinol. 1999;13:307-319.
15. Fimiani C, Mattocks DW, Cavani F, Salzet M, Deutsch DG, Pryor SC, Bilfinger TV, Stefano GB. Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial cells: coupling to nitric oxide release. Cell Signal. 1999;11:189-193.
16. Breton C, Pechoux C, Morel G, Zingg HH. Oxytocin receptor messenger ribonucleic acid: characterization, regulation, and cellular localization in the rat pituitary gland. Endocrinology. 1995;136:2928-2932.
17. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, Chambon P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature. 1986;320:134-138.
18. Mosselman S, Polman J, Dijkema R. ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett. 1996;392: 49-53.
19. Allen RW, Trach KA, Hoch JA. Identification of the 37-kDa protein displaying a variable interaction with the erythroid cell membrane as glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem. 1987;262: 649-653.
20. Roque M, Heras M, Roig E, Masotti M, Rigol M, Betriu A, Balasch J, Sanz G. Short-term effects of transdermal estrogen replacement therapy on coronary vascular reactivity in postmenopausal women with angina pectoris and normal results on coronary angiograms. J Am Coll Cardiol. 1998;31:139-143.
21. Miyahara K, Kawamoto T, Sase K, Yui Y, Toda K, Yang LX, Hattori R, Aoyama T, Yamamoto Y, Doi Y. Cloning and structural characterization of the human endothelial nitric-oxide-synthase gene. Eur J Biochem. 1994;223:719-726.
22. Hodges YK, Richer JK, Horowitz LD. Variant estrogen and progesterone receptor messages in human vascular smooth muscle. Circulation. 1999; 99:2688-2693.
23. Diano S, Horvath TL, Mor G, Register T, Adams M, Harada N, Naftolin F. Aromatase and estrogen receptor immunoreactivity in the coronary arteries of monkeys and human subjects. Menopause. 1999;6:21-28.